-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Maravai Lifesciences Holdings, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q2 2025.
- Maravai Lifesciences Holdings, Inc. Depreciation for the quarter ending June 30, 2025 was $5.96M, a 7.22% increase year-over-year.
- Maravai Lifesciences Holdings, Inc. Depreciation for the twelve months ending June 30, 2025 was $22.2M, a 20.8% increase year-over-year.
- Maravai Lifesciences Holdings, Inc. annual Depreciation for 2024 was $20.9M, a 61.7% increase from 2023.
- Maravai Lifesciences Holdings, Inc. annual Depreciation for 2023 was $12.9M, a 70.5% increase from 2022.
- Maravai Lifesciences Holdings, Inc. annual Depreciation for 2022 was $7.57M, a 18% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)